Paul G. O’Reilly

1.5k total citations
51 papers, 1.0k citations indexed

About

Paul G. O’Reilly is a scholar working on Molecular Biology, Oncology and Artificial Intelligence. According to data from OpenAlex, Paul G. O’Reilly has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Artificial Intelligence. Recurrent topics in Paul G. O’Reilly's work include AI in cancer detection (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Paul G. O’Reilly is often cited by papers focused on AI in cancer detection (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Paul G. O’Reilly collaborates with scholars based in United Kingdom, Canada and United States. Paul G. O’Reilly's co-authors include Luc A. Sabourin, Darragh G. McArt, Simona Wagner, Manuel Salto‐Tellez, Philip D. Dunne, Peter Hamilton, Ahmed Serag, Jim Diamond, Adrian Ion‐Mărgineanu and Hammad Qureshi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Paul G. O’Reilly

47 papers receiving 1.0k citations

Peers

Countries citing papers authored by Paul G. O’Reilly

Since Specialization

Citations

This map shows the geographic impact of Paul G. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. O’Reilly more than expected).

Fields of papers citing papers by Paul G. O’Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. O’Reilly. The network helps show where Paul G. O’Reilly may publish in the future.

Co-authorship network of co-authors of Paul G. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. O’Reilly. A scholar is included among the top collaborators of Paul G. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. O’Reilly. Paul G. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of artificial intelligence on biomarker discovery 2025 ·Emerging Topics in Life Sciences ·(unknown), (unknown), (unknown), Jack Monahan, Paul G. O’Reilly, Manik Garg, (unknown), Mahmoud Khasawneh, (unknown), Deepak Ganta, Thomas M. Stubbs, Benjamin B. Sun, Dimitrios Vitsios, Daniel E. Martin‐Herranz	1
2	KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer 2024 ·Biomedical Physics & Engineering Express ·Vivek Kumar Singh, (unknown), Md. Mostafa Kamal Sarker, (unknown), (unknown), (unknown), (unknown), Jacqueline A. James, Manuel Salto‐Tellez, Paul G. O’Reilly, Perry Maxwell	1
3	Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption 2023 ·Oncogene ·(unknown), Paul G. O’Reilly, Perry Maxwell, Jacqueline A. James, Darragh G. McArt, Manuel Salto‐Tellez	17
4	True-T – Improving T-cell response quantification with holistic artificial intelligence based prediction in immunohistochemistry images 2023 ·Computational and Structural Biotechnology Journal ·(unknown), Vivek Kumar Singh, Stephanie G. Craig, (unknown), (unknown), Maurice B. Loughrey, (unknown), (unknown), Paul G. O’Reilly, Jacqueline A. James, Perry Maxwell, Manuel Salto‐Tellez	7
5	Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts 2022 ·Computational and Structural Biotechnology Journal ·(unknown), (unknown), (unknown), Paul G. O’Reilly, Melissa J. LaBonte, Suneil Jain, Darragh G. McArt	0
6	Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer 2021 ·BMC Urology ·B. Bibby, Niluja Thiruthaneeswaran, Lingjian Yang, (unknown), (unknown), Darragh G. McArt, Paul G. O’Reilly, Robert G. Bristow, Kaye J. Williams, Ananya Choudhury, Catharine West	6
7	RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer 2020 ·Cell Death and Disease ·Hajrah Khawaja, Andrew D. Campbell, Jamie Z. Roberts, (unknown), Paul G. O’Reilly, Darragh G. McArt, Wendy L. Allen, Joanna Majkut, Markus Rehm, Alberto Bardelli, Federica Di Nicolantonio, Christopher J. Scott, Richard D. Kennedy, Nicolas Vitale, Timothy Harrison, Owen J. Sansom, Daniel B. Longley, Emma Evergren, Sandra Van Schaeybroeck	14
8	ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA 2019 ·Cancer Research ·(unknown), (unknown), Kienan I. Savage, Paul G. O’Reilly, (unknown), Philip D. Dunne, Mark Lawler, Simon S. McDade, David Waugh, Darragh G. McArt	6
9	Translational AI and Deep Learning in Diagnostic Pathology 2019 ·Frontiers in Medicine ·Ahmed Serag, Adrian Ion‐Mărgineanu, Hammad Qureshi, (unknown), (unknown), Jim Diamond, Paul G. O’Reilly, Peter Hamilton	168
10	Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification 2017 ·Nature Communications ·Philip D. Dunne, (unknown), Paul G. O’Reilly, (unknown), Amy M.B. McCorry, Susan D. Richman, Tim Maughan, Simon S. McDade, Patrick G. Johnston, Daniel B. Longley, Elaine W. Kay, Darragh G. McArt, Mark Lawler	53
11	Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival 2017 ·Modern Pathology ·(unknown), Philip D. Dunne, Aidan Cole, Paul G. O’Reilly, Darragh G. McArt, (unknown), (unknown), Stephen McQuaid, Maurice B. Loughrey, Graeme I. Murray, Leslie Samuel, Mark Lawler, Richard H. Wilson, Manuel Salto‐Tellez, Vicky M. Coyle	21
12	Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy 2016 ·Cancer Immunology Research ·Philip D. Dunne, Darragh G. McArt, Paul G. O’Reilly, Helen G. Coleman, Wendy L. Allen, Maurice B. Loughrey, Sandra Van Schaeybroeck, Simon S. McDade, Manuel Salto‐Tellez, Daniel B. Longley, Mark Lawler, Patrick G. Johnston	31
13	Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer 2016 ·Clinical Cancer Research ·Philip D. Dunne, Darragh G. McArt, Conor A. Bradley, Paul G. O’Reilly, Helen L. Barrett, Robert Cummins, (unknown), Ken Arthur, Maurice B. Loughrey, Wendy L. Allen, Simon S. McDade, David Waugh, Peter W. Hamilton, Daniel B. Longley, Elaine W. Kay, Patrick G. Johnston, Mark Lawler, Manuel Salto‐Tellez, Sandra Van Schaeybroeck	103
14	QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics 2016 ·BMC Bioinformatics ·Paul G. O’Reilly, Qing Wen, Peter Bankhead, Philip D. Dunne, Darragh G. McArt, (unknown), Peter W. Hamilton, Ken Mills, Shudong Zhang	25
15	Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations 2015 ·Bioorganic & Medicinal Chemistry Letters ·Ajoy Basak, Mukunda Goswami, (unknown), (unknown), Swapan Majumdar, Paul G. O’Reilly, (unknown), Vance L. Trudeau, Amit Basak	6
16	Co-acting gene networks predict TRAIL responsiveness of tumour cells with high accuracy 2014 ·BMC Genomics ·Paul G. O’Reilly, Csaba Ortutay, (unknown), Enda O’Connell, Cathal Seoighe, Susan Boyce, Luís Serrano, Éva Szegezdi	3
17	Distinct roles for Ste20-like kinase SLK in muscle function and regeneration 2013 ·Skeletal Muscle ·(unknown), Khalid N. Al‐Zahrani, Roshan K. Sriram, (unknown), Paul G. O’Reilly, (unknown), (unknown), Rashmi Kothary, Catherine Tsilfidis, Luc A. Sabourin	10
18	The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility 2009 ·Oncogene ·(unknown), Simona Wagner, (unknown), Paul G. O’Reilly, Vivian Lo, Jason J. Northey, Juliann Chmielecki, William J. Muller, Peter M. Siegel, Luc A. Sabourin	34
19	The Ste20-like Kinase SLK Is Required for Cell Cycle Progression through G2 2005 ·Journal of Biological Chemistry ·Paul G. O’Reilly, Simona Wagner, Douglas J. Franks, (unknown), Edith Browaeys, Colette Dissous, Luc A. Sabourin	47
20	Measurement of Exhaust Gas Temperatures in a High Performance Two-Stroke Engine 1998 ·SAE technical papers on CD-ROM/SAE technical paper series ·Robert J. Kee, Paul G. O’Reilly, Robert Fleck, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact